Inc.

Brean Murray, Carret & Co., despite its Buy and Hold ratings for The Wet Seal (NASDAQ: WTSLA) and bebe Stores, Inc. (NASDAQ: BEBE) respectively, they advise against aggressive buying of either currently. WTSLA closed at $4.23 and BEBE at $5.81 on Friday.

Sterne Agee has reported on Jos. A. Bank Clothiers, Inc.'s (NASDAQ: JOSB) fourth quarter preview. According to Sterne Agee, "JOSB is likely to release its 10-K no later than next Wednesday, March 30, with a conference call to follow (no date as yet set). Our Q4 estimate is $1.41 against $1.28 (or...

Benchmark has issued a report reiterating Perry Ellis International, Inc.'s (NASDAQ: PERY) Buy Rating. According to Benchmark, "Revenues increased on solid growth of the core Perry Ellis men's apparel, and continued strength in the Hispanic and Golf segments. We maintained our FY12 estimate, and...

Sterne Agee has published a report on the strong results and positive outlook for Shoe Carnival, Inc. (NASDAQ: SCVL). Sterne Agee writes, “We are confident that the later Easter will likely result in 1Q11 sales surpassing guidance, despite the difficult comparison due to toning shoes last year....

Morgan Stanley has discontinued coverage of the following companies: The Southern Company (NYSE: SO)Public Service Enterprise Group, Inc. (NYSE: PEG)Progress Energy Inc. (NYSE: PGN)PPL Corporation (NYSE: PPL)Pinnacle West Capital Corporation (NYSE: PNW)Sempra Energy (NYSE: SRE)UIL Holdings Corp. (...

Sterne Agee has reported on the fourth quarter results of Guess?, Inc. (NYSE: GES). According to Sterne Agee, "GES reported Q4 results of $1.11 aided by $0.05 in one-time loyalty program breakage. Results were $1.11 above SA/FC at $1.05 and guidance of $1.02-$1.06. Sales were $757 million – above...

Oppenheimer issued a report of the expected outcome of the retail earnings reported this week from New York & Company Inc. (NYSE: NWY), Pacific Sunwear of California, Inc. (NASDAQ: PSUN), Lululemon Athletica Inc. (NASDAQ: LUL) and Ross Stores Inc. (NASDAQ: ROST). In the report Oppenheimer...

Morgan Keegan has released a report, in which the Price Target of RadNet, Inc. (NASDAQ: RDNT) was raised from $3.40 to $4.30. Morgan Keegan reports, “We are raising our 2011 adjusted EBITDA estimate for RadNet from $114 million to $118 million and our 2012 estimate from $125 million to $126...

In a recent report by Sterne Agee, Libya exposure is a key concern for Hill International, Inc. (NYSE: HIL). Sterne Agee asserted that “HIL was averaging CFR of ~$6M/month (19% of total) in Libya and more importantly has $60M of accounts receivable (33% of total) in the country, with ~$40M-$45M...

According to Morgan Keegan, Concho Resources, Inc (CXO), stock is up more that 130% since year-end 2009. Morgan Keegan commented that “Although production is expected to grow substantially in 2011 (up 45%), coupled with best-in-class margins and exploration upside in the Permian, we think the...

J.P. Morgan has conducted a survey of 2-D and 3-D movie ticket prices for DreamWorks Animation (NASDAQ: DWA) film "Mars Needs Moms" in ten major metropolitan markets. In the survey, J.P. Morgan writes that “Average 3-D upcharge in the ten markets surveyed is $3.78 for adults and $3.75 for children...

Piper Jaffray has published a report detailing the failed snow related growth formerly anticipated for Douglas Dynamics, Inc. (NYSE: PLOW). In the report, Piper Jaffray writes “Snow related growth we envisioned in 4Q proved elusive as storms in the NE were too late to effect results. Headline EPS...

Piper Jaffray has published a report detailing the failed snow related growth formerly anticipated for Douglas Dynamics, Inc. (NYSE: PLOW). In the report, Piper Jaffray writes “Snow related growth we envisioned in 4Q proved elusive as storms in the NE were too late to effect results. Headline EPS...

Shares of MetLife, Inc. (NYSE: MET) are currently trading at $43.97, down 4.69% from $46.04 at yesterday's close. Thus far, the trading range for MET has been from a high of $44.77 to a low of $43.74 today. The average price target analysts have for this stock is $54.53, according to Yahoo! (NASDAQ...

J.P. Morgan has published a report on AVEO Pharmaceuticals (NASDAQ: AVEO). According to the report, the partnership with Tivozanib is a big win. “With this partnership, we now believe there is adequate funding to develop tivozanib in additional indications, which was a concern previously. Aveo will...